Glenmark Pharmaceuticals has informed about a Press Release dated September 04, 2015 titled ‘Glenmark Pharmaceuticals receives ANDA approval for Voriconazole Tablets, 50 mg and 200 mg’.
The above information is a part of company’s filings submitted to BSE.